ArticleCureus2026
Prospective Evaluation of Radiocephalic Arteriovenous Fistula Outcomes in a High-Volume Centre: Patency, Complications, and Influencing Factors.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Despite strong recommendations by the National Kidney Foundation (NKF) for the creation of radiocephalic arteriovenous fistula (RC AVF), most volume centres are reluctant due to contradictory complication rates and sustained patency. Factors influencing outcomes warrant attention, emphasising the importance of tailored approaches. Multicentre studies are recommended for broader validation of these findings. Therefore, the current study aimed to evaluate the outcome of RC AVF in our setup and to identify factors that influence its outcome. Method The prospective observational study was conducted at the Department of Vascular Surgery, Combined Military Hospital Lahore, over a year (October 2022-September 2023), and included 315 patients with RC AVF. Data were collected for demographic variables, comorbidities and fistula patency. The patients were further categorised into three subgroups on the basis of the location of RC AVF: snuff box, distal at the wrist, and proximal in the forearm. Follow-up evaluations were performed at one, six, and 12 weeks postoperatively. Statistical analysis was conducted using SPSS (IBM SPSS Statistics for Windows, IBM Corp., Version 22, Armonk, NY). The result shows that there was male predominance (75.2%). Results The mean age was 51.71 ± 14.94 years. Diabetes mellitus (40.6%) and hypertension (36.8%) were the most prevalent comorbidities. Distal radiocephalic arteriovenous fistula (DRC AVF) at the wrist was the most common access type (47.3%). Complications occurred in 9.2% of patients. Primary patency rates were 98.7% at one week, 92.1% at six weeks, and 90.5% at 12 weeks. Conclusion Radiocephalic fistula demonstrates favourable outcomes in our high-volume centre, with low complication rates and sustained patency. Factors influencing outcomes warrant attention, emphasising the importance of tailored approaches. Multicentre studies are recommended for broader validation of these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.